{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:59Z","timestamp":1791073679819,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0105266","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T19:20:08Z","timestamp":1408044008000},"page":"e105266","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route"],"prefix":"10.1371","volume":"9","author":[{"given":"Fanny","family":"Edele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Dudda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bachtanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanspeter","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"K Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.13.22","article-title":"Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies","volume":"12","author":"P Kalinski","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejcb.2011.01.012","article-title":"Third generation dendritic cell vaccines for tumor immunotherapy","volume":"91","author":"B Frankenberger","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1172\/JCI9051","article-title":"Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes","volume":"105","author":"MV Dhodapkar","year":"2000","journal-title":"J Clin Invest"},{"key":"ref5","first-page":"5091","article-title":"Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients","volume":"9","author":"IJ de Vries","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"FJ Hsu","year":"1996","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V99.5.1517","article-title":"Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients","volume":"99","author":"JM Timmerman","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.166.6.4254","article-title":"Dendritic cells injected via different routes induce immunity in cancer patients","volume":"166","author":"L Fong","year":"2001","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1073\/pnas.141226398","article-title":"Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy","volume":"98","author":"L Fong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"FO Nestle","year":"1998","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","volume":"190","author":"B Thurner","year":"1999","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI6909","article-title":"Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells","volume":"104","author":"MV Dhodapkar","year":"1999","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"SA Rosenberg","year":"2004","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2011.11.058","article-title":"Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer","volume":"30","author":"RB Sims","year":"2012","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1084\/jem.20021348","article-title":"Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control","volume":"198","author":"DW Mullins","year":"2003","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.172.2.857","article-title":"Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets","volume":"172","author":"JC Dudda","year":"2004","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"L Ohl","year":"2004","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1532\/IJH97.04164","article-title":"Migration of dendritic cells","volume":"81","author":"H Yoneyama","year":"2005","journal-title":"Int J Hematol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni928","article-title":"Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes","volume":"4","author":"P Bousso","year":"2003","journal-title":"Nat Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.176.8.4535","article-title":"Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes","volume":"176","author":"DW Mullins","year":"2006","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/eji.200425817","article-title":"Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments","volume":"35","author":"JC Dudda","year":"2005","journal-title":"Eur J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.181.6.3745","article-title":"Cutting edge: instructive role of peripheral tissue cells in the imprinting of T cell homing receptor patterns","volume":"181","author":"F Edele","year":"2008","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20080039","article-title":"Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo","volume":"205","author":"SI Hammerschmidt","year":"2008","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.4049\/jimmunol.0900311","article-title":"Lymph node stromal cells support dendritic cell-induced gut-homing of T cells","volume":"183","author":"R Molenaar","year":"2009","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2004.12.008","article-title":"Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs","volume":"22","author":"T Calzascia","year":"2005","journal-title":"Immunity"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/342559a0","article-title":"Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen","volume":"342","author":"H Pircher","year":"1989","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.183.4.1367","article-title":"Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts","volume":"183","author":"C Zimmerman","year":"1996","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/eji.1830230834","article-title":"T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides","volume":"23","author":"D Kyburz","year":"1993","journal-title":"Eur J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4049\/jimmunol.161.5.2187","article-title":"Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo","volume":"161","author":"A Prevost-Blondel","year":"1998","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80469-0","article-title":"Massive expansion of antigen-specific CD8+ T cells during an acute virus infection","volume":"8","author":"EA Butz","year":"1998","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection","volume":"8","author":"K Murali-Krishna","year":"1998","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-5355-7_14","article-title":"In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection","volume":"452","author":"K Murali-Krishna","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1158\/1078-0432.CCR-05-2421","article-title":"Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes","volume":"12","author":"A Grover","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.20030448","article-title":"Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming","volume":"198","author":"A MartIn-Fontecha","year":"2003","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.it.2004.05.008","article-title":"Tissue targeting of T cells by DCs and microenvironments","volume":"25","author":"JC Dudda","year":"2004","journal-title":"Trends Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4049\/jimmunol.178.3.1512","article-title":"Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells","volume":"178","author":"SL Sheasley-O\u2019Neill","year":"2007","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.181.3.1814","article-title":"Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics","volume":"181","author":"CC Brinkman","year":"2008","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2008.04.010","article-title":"Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection","volume":"28","author":"JJ Obar","year":"2008","journal-title":"Immunity"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.4049\/jimmunol.172.8.4875","article-title":"Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin","volume":"172","author":"D Masopust","year":"2004","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.183.1.87","article-title":"Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines","volume":"183","author":"L Zitvogel","year":"1996","journal-title":"J Exp Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.coi.2008.04.003","article-title":"TGF-beta and tumors\u2013an ill-fated alliance","volume":"20","author":"NM Moutsopoulos","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14712590802715756","article-title":"Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer","volume":"9","author":"MA Morse","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00432-008-0393-3","article-title":"Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival","volume":"134","author":"G Xu","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-11-3538","article-title":"The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor","volume":"72","author":"JP Abastado","year":"2012","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0105266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T23:33:01Z","timestamp":1689463981000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0105266"}},"subtitle":[],"editor":[{"given":"Natalia","family":"Lapteva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0105266","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}